e-commerce
Read The Flipping Licence
(Via Techdirt). It has become an internet cliché to point out that nobody reads click-wrap agreements. There is the now famous story of the anti-spyware software that included the promise to pay some money to the first person who emailed them. It took four months for somebody to email them, Read more…
Google
Google in trouble?
Google Print continues to suffer from mounting opposition from publishers and authors. It has been reported that it was sued by the Author’s Guild, but it is now also being sued by the Association of American Publishers, which includes some big names like McGraw-Hill, Pearson Education and Penguin. In Europe Read more…
Google
Meet Google, the boy
The Google blog has the story of Oliver Google Kai, born in Sweden from two technology enthusiasts who, you guessed it, love Google. Fortunately I do not have any offspring, otherwise there could be a little Wikipedia walking the streets of Edinburgh.
Regulation
The Adelphi Charter
I have finally managed to read the Adelphi Charter on Creativity, Innovation and Intellectual Property (formerly known as the IP Charter). The Charter was drafted by a distinguished panel of IP law experts, creators and activists (including Professor Hector MacQueen). Some other people assisted with the research process, such as Read more…
Announcements
Opening lecture at Edinburgh
This year’s opening lecture at the AHRC Centre for studies in IP and Technology Law at the University of Edinburgh was held last night. Professor Jonathan Zittrain, the new Chair of Internet Governance and Regulation at the Oxford Internet Institute, gave an excellent talk entitled “The Future of the Internet Read more…
Google
Google bombing at work
(received via the Cyberprof mailing list) Go to Google and type “Failure”, then hit “I’m feeling lucky”. Then much fun ensues, and the people rejoice and giggle.
Open science
Access to medicines debate back to the table?
The nightly news are filled with stories about the bird flu and the prospect of a pandemic that will kill millions of people. But it has also brought one issue back to the table, the access to medicines debate. There are reports that there is only one antiviral drug that Read more…